WHO 2021 and beyond: new types, molecular markers and tools for brain tumor classification

S Tran, F Bielle - Current Opinion in Oncology, 2022 - journals.lww.com
New diagnostic criteria and better definitions of tumor types aim at improving the
management of brain tumor patients and at better evaluating new treatments in clinical trials …

Adult medulloblastoma: updates on current management and future perspectives

E Franceschi, C Giannini, J Furtner, KW Pajtler, S Asioli… - Cancers, 2022 - mdpi.com
Simple Summary Adult medulloblastoma is an extremely rare tumor of the central nervous
system. Standard multimodal treatment, comprising maximal safe surgical resection followed …

Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation–Sparing Approaches: An International Cohort Study

C Erker, M Mynarek, S Bailey, CM Mazewski… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE Infant and young childhood medulloblastoma (iMB) is usually treated without
craniospinal irradiation (CSI) to avoid neurocognitive late effects. Unfortunately, many …

Inter and intra-tumoral heterogeneity as a platform for personalized therapies in medulloblastoma

M Danilenko, SC Clifford, EC Schwalbe - Pharmacology & Therapeutics, 2021 - Elsevier
Medulloblastoma is the most common malignant CNS tumor of childhood, affecting~ 350
patients/year in the USA. In 2020, most children are cured of their disease, however …

Posterior fossa tumours in the first year of life: a two-centre retrospective study

S Picariello, P Spennato, J Roth, N Shimony, A Marini… - Diagnostics, 2022 - mdpi.com
Posterior fossa tumours (PFTs) in infants are very rare, and information on these tumours is
scarce in the literature. This retrospective study reports their pathological characteristics and …

Clinical, histological, and molecular prognostic factors in childhood medulloblastoma: where do we stand?

C Ntenti, K Lallas, G Papazisis - Diagnostics, 2023 - mdpi.com
Medulloblastomas, highly aggressive neoplasms of the central nervous system (CNS) that
present significant heterogeneity in clinical presentation, disease course, and treatment …

Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups

S Tonn, A Korshunov, D Obrecht, M Sill… - Neuro …, 2023 - academic.oup.com
Background The prognostic impact of clinical risk factors and DNA methylation patterns in
sonic hedgehog (SHH)-activated early childhood desmoplastic/nodular medulloblastoma …

[HTML][HTML] Review of the Recent Changes in the WHO Classification for Pediatric Brain and Spinal Cord Tumors

AM Halfpenny, MD Wood - Pediatric Neurosurgery, 2023 - karger.com
Background: Periodic updates to the World Health Organization (WHO) classification system
for central nervous system (CNS) tumors reflect advances in the pathological diagnosis …

Radiotherapy for Primary Pediatric Central Nervous System Malignancies: Current Treatment Paradigms and Future Directions

KX Liu, DA Haas-Kogan, H Elhalawani - Pediatric neurosurgery, 2023 - karger.com
Background: Central nervous system tumors are the most common solid tumors in
childhood. Treatment paradigms for pediatric central nervous system malignancies depend …

Population-based analysis of CNS tumor diagnoses, treatment, and survival in congenital and infant age groups

M Hart, A Anderson-Mellies, A Beltrami, A Gilani… - Journal of Neuro …, 2022 - Springer
Abstract Background Congenital (< 3 months) and infant (3 to 11 months) brain tumors are
biologically different from tumors in older children, but their epidemiology has not been …